Abstract
Atherosclerosis represents an inflammatory response to the disturbance of the endothelial layer in the arterial bloodstream. In the present study, an analysis of associations of polymorphic markers for the genes controlling synthesis of proteins involved in atherosclerosis pathogenesis in coronary atherosclerosis (CA) patients (217 subjects) and in a control group (250 subjects) was conducted. The following genes were examined: rs991804 (CCL2 gene), rs1126579 (CXCR2 gene), rs4074 (CXCL1 gene), rs4073 (CXCL8 gene), rs333 (CCR5 gene), rs2471859 (CXCR4 gene), rs1801157 (CXCL12 gene), and rs2569190 (CD14 gene). Using the Monte Carlo and Markov chain (APSampler) method, allele/genotype combinations associated with both low and high CA risk were revealed. The most important findings included the following: CXCR4*T/T + CCL2*C + CCR5*I/I (P perm = 1 × 10–6, OR = 0.44, 95% CI 0.3–0.63), CXCR2*C + CD14*C + CXCL12*G + CCL2*C + CCR5*D (P perm = 4 × 10–6, OR = 5.78, 95% CI 2.34–14.28), CD14*C + CCL2*C/C + CCR5*D (P perm = 6.3 × 10–6, OR = 5.81, 95% CI 2.17–15.56), CXCL8*A + CXCR2*C + CD14*T + CXCR4*C (P perm = 0.01, OR = 3.21, 95% CI 1.63–6.31).
Similar content being viewed by others
References
Ross, R., Atherosclerosis—an inflammatory disease, N. Engl. J. Med., 1999, vol. 340, no. 2, pp. 115–126. doi 10.1056/nejm199901143400207
Legein, B., Temmerman, L., Biessen, E.A., and Lutgens, E., Inflammation and immune system interactions in atherosclerosis, Cell. Mol. Life Sci., 2013, vol. 70, no. 20, pp. 3847–3869. doi 10.1007/s00018- 013-1289-1
Bruserud, Ø. and Kittang, A.O., The chemokine system, in The Chemokine System in Experimental and Clinical Hematology, Berlin: Springer-Verlag, 2010, pp. 3–12. doi 10.1007/978-3-642-12639-0
Hoogeveen, R.C., Morrison, A., Boerwinkle, E., et al., Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: atherosclerosis risk in communities study, Atherosclerosis, 2005, vol. 183, no. 2, pp. 301–307. doi 10.1016/jatherosclerosis. 2005.03.007
Gu, L., Okada, Y., Clinton, S.K., et al., Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice, Mol. Cell, 1998, vol. 2, no. 2, pp. 275–281. doi 10.1016/S1097-2765(00)80139-2
Boring, L., Gosling, J., Cleary, M., et al., Decreased lesion formation in CCR2–/–mice reveals a role for chemokines in the initiation of atherosclerosis, Nature, 1998, vol. 394, no. 6696, pp. 894–897. doi 10.1038/29788
Boisvert, W.A., Rose, D.M., Johnson, K.A., et al., Upregulated expression of the CXCR2 ligand KC/GROalpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression, Am. J. Pathol., 2006, vol. 168, no. 4, pp. 1385–1395. doi 10.2353/ajpath.2006.040748
Papadopoulou, C., Corrigall, V., Taylor, P.R., et al., The role of the chemokines MCP-1, GRO-alpha, IL-8 and their receptors in the adhesion of monocytic cells to human atherosclerotic plaques, Cytokine, 2008, vol. 43, no. 2, pp. 181–186. doi 10.1016/jcyto.2008.05.009
Soehnlein, O., Drechsler, M., Döring, Y., et al., Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes, EMBO Mol. Med., 2013, vol. 5, no. 3, pp. 471–481. doi 10.1002/emmm.201201717
Boisvert, W.A., Curnss, L.K., and Terkeltaub, R.A., Interleukin-8 and its receptor CXCR2 in atherosclerosis, Immunol. Res., 2000, vol. 21, nos. 2–3, pp. 129–137. doi 10.1385/IR:21:2-3:129
Neumann, F.J., Ott, I., Gawaz, M., et al., Cardiac release of cytokines and inflammatory responses in acute myocardial infarction, Circulation, 1995, vol. 92, no. 4, pp. 748–755. doi 10.1161/01.CIR.92.4.748
Yeh, M., Leitinger, N., de Martin, R., et al., Increased transcription of IL-8 in endothelial cells is differentially regulated by TNF- and oxidized phospholipids, Arterioscler. Thromb. Vasc. Biol., 2001, vol. 21, no. 10, pp. 1585–1591. doi 10.1161/hq1001.097027
Zernecke, A., Liehn, E.A., Gao, J.L., et al., Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosispronemice: involvement of IL-10, Blood, 2006, vol. 107, no. 11, pp. 4240–4243. doi 10.1182/blood-2005-09-3922
Potteaux, S., Combadiere, C., Esposito, B., et al., Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice, Arterioscler. Thromb. Vasc. Biol., 2006, vol. 26, no. 8, pp. 1858–1863. doi 10.1161/01.ATV.0000231527.22762.71
Bot, I., Daissormont, I.T., Zernecke, A., et al., CXCR4 blockade induces atherosclerosis by affecting neutrophil function, J. Mol. Cell. Cardiol., 2014, vol. 74, pp. 44–52. doi 10.1016/jyjmcc.2014.04.021
Liao, W., Endotoxin: possible roles in initiation and development of atherosclerosis, J. Lab. Clin. Med., 1996, vol. 128, no. 5, pp. 452–460. doi 10.1016/S0022-2143(96)90042-6
Barnes, P.J. and Karin, M., Nuclear factor-kB: a pivotal transcription factor in chronic inflammatory diseases, N. Engl. J. Med., 1997, vol. 336, no. 15, pp. 1066–1071. doi 10.1056/nejm199704103361506
Sambrook, J., Fritsch, E.F. and Maniatis, T., Molecular Cloning, New York: Cold Spring Harbor Lab., 1989, vol. 2, p. 14–9.23.
Favorov, A.V., Andreewski, T.V., Sudomoina, M.A., et al., A Markov chain Monte Carlo technique for identification of combinations of allelic variants underlying complex diseases in humans, Genetics, 2005, vol. 171, no. 4, pp. 2113–2121. doi 10.1534/genetics.105.048090
Lima-Neto, L.G., Hirata, R.D.C., Luchessi, A.D., et al., CD14 and IL6 polymorphisms are associated with a pro-atherogenic profile in young adults with acute myocardial infarction, J. Thromb. Thrombolysis, 2013, vol. 36, no. 3, pp. 332–340. doi 10.1007/s11239-012-0841-4
Hubacek, J.A., Pit’ha, J., Škodová, Z., et al., C (–260) ? T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction, Circulation, 1999, vol. 99, no. 25, pp. 3218–3220. doi 10.1161/01cir.99.25.3218
Hermanna, M., Fischer, D., Hoffmannc, M.M., et al., CRP and CD14 polymorphisms correlate with coronary plaque volume in patients with coronary artery disease IVUS substudy of the ENCORE trials, Atherosclerosis, 2012, vol. 220, no. 1, pp. 172–176. doi 10.1016/jatherosclerosis.2011.10.019
Morange, P.E., Tiret, L., Saut, N., et al., TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: the PRIME study, Eur. J. Human Genet., 2004, vol. 12, no. 12, pp. 1041–1049. doi 10.1038/sjejhg.5201277
Song, M. and Cho, S., CD14 acts as an angiogenic factor by inducing basic fibroblast growth factor (bFGF), Bull. Korean Chem. Soc., 2007, vol. 28, no. 9, p. 1613.
Sedlmeier, E.M., Grallert, H., Huth, C., et al., Gene variants of monocyte chemoattractant protein 1 and components of metabolic syndrome in KORA S4, Augsburg, Eur. J. Endocrinol., 2007, vol. 156, no. 3, pp. 377–385. doi 10.1530/eje.1.02345
Nasibullin, T.R., Belonogova, V.A., Tuktarova, I.A., et al., Association of the CCL2 polymorphic markers with essential hypertension, Russ. J. Genet., 2011, vol. 47, no. 9, pp. 1124–1127. doi 10l134/S10227954-11090134
Rovin, B.H., Lu, L., and Saxena, R., A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression, Biochem. Biophys. Res. Commun., 1999, vol. 259, no. 2, pp. 344–348. doi 10.1006/bbrc.1999.0796
McDermott, D.H., Yang, Q., Kathiresan, S., et al., CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study, Circulation, 2005, vol. 112, no. 8, pp. 1113–1120. doi 10.1161/circulationaha.105.543579
Fujiyama, S., Amano, K., Uehira, K., et al., Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells, Circ. Res., 2003, vol. 93, no. 10, pp. 980–989. doi 10.1161/01res.0000099245.08637
Hong, K.H., Ryu, J., and Han, K.H., Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A, Blood, 2005, vol. 105, no. 4, pp. 1405–1407. doi 10.1182/blood-2004-08-3178
Stamatovic, S.M., Keep, R.F., Mostarica-Stojkovic, M., and Andjelkovic, A.V., CCL2 regulates angiogenesis via activation of Ets-1 transcription factor, J. Immunol., 2006, vol. 177, no. 4, pp. 2651–2661. doi 10.4049/jimmunol.177.4.2651
Sudomoina, M.A., Sukhinina, T.S., Barsova, R.M., et al., Complex analysis of association of inflammation gene polymorphisms with myocardial infarction, Mol. Biol. (Moscow), 2010, vol. 44, no. 3, pp. 407–414. doi 10l134/s0026893310030088
Breunis, W.B., Biezeveld, M.H., Geissler, J., et al., Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease, Clin. Exp. Immunol., 2007, vol. 150, no. 1, pp. 83–90. doi 10.1111/j.1365-2249.2007.03457x
Dinh, K.M., Pedersen, O.B., Petersen, M.S., et al., The impact of CCR5-32 deletion on C-reactive protein levels and cardiovascular disease: results from the Danish blood donor study, Atherosclerosis, 2015, vol. 242, no. 1, pp. 222–225. doi 10.1016/jatherosclerosis. 2015.07.031
Singh, N., Sinha, N., Kumar, S., et al., Polymorphism in chemokine receptor genes and risk of acute myocardial infarction in North Indian population, Mol. Biol. Rep., 2012, vol. 39, no. 3, pp. 2753–2759. doi 10.1007/s11033-011-1031-8
Zhang, Z., Liu, J., Wang, H., et al., Association between chemokine receptor 5 (CCR5) delta32 gene variant and atherosclerosis: a meta-analysis of 13 studies, Int. J. Clin. Exp. Med., 2015, vol. 8, no. 1, p. 658.
Braunersreuther, V., Zernecke, A., Arnaud, C., et al., Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice, Arterioscler. Thromb. Vasc. Biol., 2007, vol. 27, no. 2, pp. 373–379. doi 10.1161/01atv.0000253886.44609ae
Quinones, M.P., Martinez, H.G., Jimene, F., et al., CC chemokine receptor 5 influences late-stage atherosclerosis, Atherosclerosis, 2007, vol. 195, no. 1. e92–e103. doi 10.1016/jatherosclerosis.2007.03.026
Mehta, N.N., Li, M., William, D., et al., The novel atherosclerosis locus at 10q11 regulates plasma CXCL12 levels, Eur. Heart. J., 2011, vol. 32, pp. 963–971. doi 10.1093/eurheartj/ehr091
de Oliveira, K.B., Guembarovski, R.L., Oda, J.M.M., et al., CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients, Cytokine, 2011, vol. 55, no. 2, pp. 260–265. doi 10.1016/jcyto.2011.04.017
Schober, A., Bernhagen, J., and Weber, C., Chemokine- like functions of MIF in atherosclerosis, J. Mol. Med., 2008, vol. 86, no. 7, pp. 761–770. doi 10.1007/s00109-008-0334
Boisvert, W.A. and Santiago, R., Curtiss, L.K., and Terkeltaub, R.A., A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptordeficient mice, J. Clin. Invest., 1998, vol. 101, no. 2, p. 353. doi 10.1172/JCI1195
Salim, P.H., Jobim, M., Bredemeier, M., et al., Combined effects of CXCL8 and CXCR2 gene polymorphisms on susceptibility to systemic sclerosis, Cytokine, 2012, vol. 60, no. 2, pp. 473–477. doi 10.1016/jcyto.2012.05.026
Javor, J., Bucova, M., Cervenova, O., et al., Genetic variations of interleukin-8, CXCR1 and CXCR2 genes and risk of acute pyelonephritis in children, Int. J. Immunogenet., 2012, vol. 39, no. 4, pp. 338–345. doi 10.1111/j.1744-313X.2012.01096x
Hildebrand, F., Stuhrmann, M., van Griensven, M., et al., Association of IL-8-251A/T polymorphism with incidence of acute respiratory distress syndrome (ARDS) and IL-8 synthesis after multiple trauma, Cytokine, 2007, vol. 37, no. 3, pp. 192–199. doi 10.1016/jcyto.2007.03.008
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © T.R. Nasibullin, L.F. Yagafarova, I.R. Yagafarov, Ya.R. Timasheva, V.V. Erdman, I.A. Tuktarova, O.E. Mustafina, 2016, published in Genetika, 2016, Vol. 52, No. 8, pp. 966–974.
Rights and permissions
About this article
Cite this article
Nasibullin, T.R., Yagafarova, L.F., Yagafarov, I.R. et al. Association of polymorphic markers of chemokine genes, their receptors, and CD14 gene with coronary atherosclerosis. Russ J Genet 52, 860–867 (2016). https://doi.org/10.1134/S1022795416060090
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1022795416060090